Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 975 of 5804
-
Weight-Loss drug may slow uterine tumors before surgery
Disease control Not yet recruitingThe goal of this study is to determine the anti-proliferative effect of tirzepatide on the endometrium of patients with endometrial intra-epithelial neoplasia (EIN) and Grade 1 endometrial cancer (EC), by comparing archival endometrial biopsy samples of patients randomized to tir…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Magic Mushroom-Like drug tested for depression and anxiety
Knowledge-focused Recruiting nowThe goal of this study is to learn how psychedelics may help symptoms of depression and anxiety. Participants with major depressive disorder experiencing symptoms of depression and anxiety will receive one dose of either a drug related to psilocybin or a placebo. Assessments incl…
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Smarter radiation planning aims to boost liver tumor attack while sparing healthy tissue
Disease control Not yet recruitingThe purpose of this study is to assess the safety and effectiveness of treating a tumor using a different planning method called MCD for the FDA-Approved device, TheraSphere. TheraSphere Microspheres are microscopic radioactive glass spheres that deliver radiation therapy in the…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Massive heart study aims to sharpen diagnosis and cut needless hospital stays
Knowledge-focused Not yet recruitingSuspected acute or subacute cardiovascular diseases-including chest pain, dyspnea, and palpitations-are among the most common reasons for unscheduled emergency department visits and pre-hospital referrals. Despite this high clinical burden, the diagnostic yield is often limited, …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Smartwatch could alert doctors to brain cancer complications before they worsen
Disease control Not yet recruitingThis research study is for participants diagnosed with leptomeningeal metastasis disease (LMM), a condition where cancer has spread to the fluid and membranes surround the brain and spinal cord. The purpose of this study is to find out whether a consumer Smartwatch can continuous…
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain zaps and therapy: a new combo to tame BPD emotions
Disease control Not yet recruitingImpaired emotion regulation is a core feature of borderline personality disorder (BPD) and a known driver of functional impairment, interpersonal difficulties, self-harm, and suicidality. Emotion regulation refers to the ways in which people influence and control which emotions t…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could early lipid screening in High-Risk kids prevent future heart attacks?
Knowledge-focused Recruiting nowPreventive measures are increasingly coming to the forefront of medicine. Many of these measures can be implemented as early as childhood and adolescence. For instance, the early detection and treatment of cardiovascular risk factors can significantly reduce long-term morbidity a…
Phase: NA • Sponsor: Alexandra Miriam Kiess • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
Disease control Not yet recruitingDelayed graft function, defined as the need for dialysis within seven days of kidney transplantation, is a common complication affecting deceased-donor kidney transplant recipients. It is associated with prolonged hospitalization, increased healthcare costs, higher rates of acute…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Steam therapy aims to zap prostate cancer without major surgery
Disease control Not yet recruitingThe goal of this study is to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation System ("Vanquish") in participants with Grade Group 3 (GG3) intermediate-risk prostate cancer. Participants will undergo therapy with the Vanquish System and complete follow …
Phase: NA • Sponsor: Francis Medical Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a single pill tame bipolar depression and obesity together?
Disease control Not yet recruitingThis research study examines how a medication called lumateperone may affect mood symptoms, and inflammation in adults with bipolar disorder over approximately 6 weeks. An MRI scan to calculate biological age of the brain will also be obtained at the start of the study.
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug SKB571 takes on recurrent head and neck cancer
Disease control Not yet recruitingThis is a multicenter, open-label, Phase II clinical study to assess the efficacy, safety, tolerability, PK characteristics, and immunogenicity of SKB571 in participants with recurrent or metastatic HNSCC.
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a VR headset cool hot flashes? new study investigates
Symptom relief Not yet recruitingThe purpose of this research is to evaluate the feasibility, acceptability, tolerability, and clinical efficacy of MenoZen VR (virtual reality) for managing menopause symptoms in women.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Spinal zap may stop deadly brain artery spasms after aneurysm
Disease control TerminatedThe purpose of the study is to see that in addition to existing therapy, how well an additional procedure named spinal cord stimulation might reduce blood vessel spasm from aneurysm rupture.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New ADHD assessment system could sharpen diagnosis in kids
Diagnosis Not yet recruitingThis clinical trial aims to evaluate the diagnostic efficacy and safety of the Attention Deficit Hyperactivity Disorder Assessment System (AHEF) in children aged 6 to 12 in China, while ensuring the safety of the subjects and maintaining the scientific integrity of the clinical t…
Sponsor: Chongqing Jinsaixing Medical Technology Co., Ltd • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New Stomach-Suturing device could help obese asians lose weight without surgery
Disease control Not yet recruitingTo demonstrate the safety and efficacy of OverStitch NXT Endoscopic Suture System for endoscopic sleeve gastroplasty(ESG) in obese populations to support the registration of OverStitch NXT for ESG indication.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Experimental virus therapy takes on deadly brain tumors
Disease control Not yet recruitingA single-arm clinical study on the efficacy and safety of the novel oncolytic virus Ad-TD-nsIL12 combined with PD-1 inhibitors in the treatment of recurrent high-grade glioma
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New study aims to make duchenne gene therapy safer for kids
Disease control Not yet recruitingThe primary objective of this study is to evaluate acute liver injury (ALI) rates associated with ELEVIDYS with the addition of sirolimus as an adjunct prophylactic immunosuppression agent.
Phase: PHASE4 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug aims to lighten heavy periods for bleeding disorder patients
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacodynamics (PD) of multiple doses of ALN-6400 in adult and adolescent patients with VWD and HMB
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New registry tracks Dupilumab's Real-World impact on COPD
Disease control Not yet recruitingThe STRIDE Registry will evaluate the real-world effectiveness and safety of dupilumab in participants with COPD. The primary objective is to describe characteristics of participants newly initiated with dupilumab for COPD. Secondary objectives are to determine whether treatment …
Sponsor: Sanofi • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New cortisol timing therapy may improve life for adults with rare hormone disorder
Disease control Not yet recruitingClassic congenital adrenal hyperplasia (CAH) is an autosomal recessive genetic disorder caused by a defect in the enzyme cascade regulating adrenal steroidogenesis; in approximately 95% of cases the defect is located in CYP21A2, the gene encoding 21-hydroxylase, and is characteri…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC